保留神经根治性前列腺切除术后阴茎康复策略:随机试验的系统综述与网络荟萃分析
该系统综述与网络荟萃分析纳入22项随机试验共2711例患者,比较16种阴茎康复策略与安慰剂对根治性前列腺切除术后勃起功能恢复的疗效。结果显示,盆底肌训练(OR 5.21,95%CrI 1.24-29.8)和100 mg西地那非规律剂量(OR 4.00,95%CrI 1.40-13.4)与勃起功能恢复可能性显著更高相关;按需剂量磷酸二酯酶-5抑制剂未优于安慰剂。
要点
- 100 mg西地那非规律剂量是改善术后勃起功能恢复的最佳策略,证据确定性中等。
- 盆底肌训练也显示有效,但证据确定性低,需更大样本随机对照试验确认。
- 按需剂量磷酸二酯酶-5抑制剂不应被视为阴茎康复策略。
核心结论
- 100 mg西地那非规律剂量是提高根治性前列腺切除术后勃起功能恢复率的最佳阴茎康复策略。
- 盆底肌训练显示可提高勃起功能恢复率,但需更大样本随机对照试验确认早期结果。
- 按需剂量磷酸二酯酶-5抑制剂不应被视为阴茎康复策略。
研究设计与样本
- 系统综述与网络荟萃分析,采用贝叶斯方法。
- 2020年5月检索PubMed和Web of Science数据库,遵循PRISMA网络荟萃分析扩展声明。
- 纳入22项研究共2711例患者,比较16种阴茎康复策略与安慰剂。
主要发现
- 与安慰剂相比,盆底肌训练与勃起功能恢复可能性显著更高相关(OR 5.21,95%CrI 1.24-29.8),证据确定性低。
- 100 mg西地那非规律剂量(每日一次或每晚一次)与勃起功能恢复可能性显著更高相关(OR 4.00,95%CrI 1.40-13.4),证据确定性中等。
- 敏感性分析显示,规律高剂量磷酸二酯酶-5抑制剂(无论类型)与安慰剂相比与勃起功能恢复可能性显著更高相关(OR 2.09,95%CrI 1.06-4.17),证据确定性中等。
- 按需剂量磷酸二酯酶-5抑制剂未证明比安慰剂更有益。
关键数值与推荐
- 盆底肌训练 vs 安慰剂:OR 5.21,95%CrI 1.24-29.8。
- 100 mg西地那非规律剂量 vs 安慰剂:OR 4.00,95%CrI 1.40-13.4。
- 规律高剂量磷酸二酯酶-5抑制剂(无论类型)vs 安慰剂:OR 2.09,95%CrI 1.06-4.17。
临床怎么用
- 对于保留神经根治性前列腺切除术后患者,可考虑100 mg西地那非规律剂量(每日一次或每晚一次)作为阴茎康复策略。
- 盆底肌训练可作为康复选项,但需告知患者证据确定性较低。
- 不推荐按需剂量磷酸二酯酶-5抑制剂用于阴茎康复。
局限性
- 次要结局如不良事件因文献数据不完整未进行分析。
- 所有研究中均未报告严重不良事件。
- 盆底肌训练的证据确定性低,需更大样本随机对照试验确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Despite the advances in nerve sparing and minimally invasive radical prostatectomy, erectile dysfunction remains an important adverse event after radical prostatectomy. Penile rehabilitation strategies have been developed to expedite and improve erectile function recovery. However, the differential efficacy and the best penile rehabilitation strategy are unclear as yet. We conducted a systematic review and network meta-analysis to investigate and compare the efficacy of different penile rehabilitation strategies. MATERIALS AND METHODS: A systematic search was performed in May 2020 using PubMed® and Web of Science™ databases according to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) extension statement for network meta-analysis. Studies that compared the erectile function recovery rate and adverse events between penile rehabilitation treatment groups (eg medications, devices and actions) and control group were included. We used the Bayesian approach in the network meta-analysis. RESULTS: A total of 22 studies (2,711 patients) met our eligibility criteria. Out of 16 different penile rehabilitation strategies and schedules vs placebo, only pelvic floor muscle training (OR 5.21, 95% CrI 1.24-29.8) and 100 mg sildenafil regular doses, ie once daily or nightly (OR 4.00, 95% CrI 1.40-13.4) were associated with a significantly higher likelihood of erectile function recovery. The certainty of results for 100 mg sildenafil regular dose was moderate, while pelvic floor muscle training had low certainty. The sensitivity analysis confirmed that the regular high dose of phosphodiesterase-5 inhibitors regardless of type vs placebo (OR 2.09, 95% CrI 1.06-4.17) was associated with a significantly higher likelihood of erectile function recovery with a moderate certainty. The on-demand doses of phosphodiesterase-5 inhibitors were not proven to be more beneficial than placebo. Secondary outcomes such as adverse events were not analyzed due to incomplete data in the literature. However, no serious adverse events were reported in any of the studies. CONCLUSIONS: Sildenafil 100 mg regular dose is the best penile rehabilitation strategy to improve erectile function recovery rates after radical prostatectomy. Although pelvic floor muscle training has been shown to be effective in increasing the erectile function recovery rate, well designed randomized controlled trials with larger sample sizes are needed to confirm the presented early results. The on-demand dose of phosphodiesterase-5 inhibitors should not be considered as a penile rehabilitation strategy.
引用
- Sari Motlagh R, Abufaraj M, Yang L, et al. Penile Rehabilitation Strategy after Nerve Sparing Radical Prostatectomy: A Systematic Review and Network Meta-Analysis of Randomized Trials. J Urol. 2021. PMID: 33443457. doi:10.1097/JU.0000000000001584
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。